期刊文献+

ESM-1作为肝癌血管内皮标志物的意义 被引量:1

Significance of Endothelial Cell Specific Molecule 1 as A Biomarker of Endothelium in Hepatocellular Carcinoma
下载PDF
导出
摘要 目的研究内皮细胞特异性分子1(ESM-1)在肝细胞癌(HCC)中的表达及其意义。方法利用表达谱芯片技术比较3例HCC和癌旁肝组织基因表达的差异,筛选出与肿瘤内皮细胞功能有关的基因群。采用免疫组织化学SABC法检测100例HCC及其癌旁肝组织和16例正常肝组织中ESM-1的表达。结果表达谱芯片技术获得112条差异表达基因,其中与内皮细胞功能有关的基因6条(包括ESM-1)。ESM-1特异性表达于HCC的血管内皮细胞,而癌旁肝组织和正常肝组织的血管内皮则几乎不表达。ESM-1的表达水平和HCC的镜下静脉浸润密切相关(P<0.05)。ESM-1高表达组的无瘤存活率低于ESM-1低表达组,差异具有统计学意义(P<0.05)。结论 ESM-1与HCC的恶性生物学行为、血管生成以及不良预后密切相关。 Objective To study the significance of the expression of endothelial cell specific molecule 1(ESM-1) in hepatocellular carcinoma(HCC).Methods The molecular profile of endothelium was studied through gene expression profiling technique in 3 cases of HCC and their respective paraneoplastic tissue.The expressions of ESM-1 in 100 samples of HCC and their corresponding paraneoplastic tissues and 16 samples of normal liver tissues were studied through immunohistochemistry assay.Results One hundred and twelve genes was differentially expressed in 3 cases of HCC,including 6 genes which were functionally correlated with endothelial cells.ESM-1 was one of the 6 genes.ESM-1 was specifically expressed in the endothelium of HCC tissues and no expression was found in the paraneoplastic liver tissues and normal liver tissue.The expression of ESM-1 in HCC with microscopic venous invasion was significantly higher than those in HCC without microscopic venous invasion(P0.05).1,2,3 cancer-free survival rates in patients with low ESM-1 expression were 61.0%,38.0% and 19.0% respectively and those in patients with high ESM-1 expression were 43.4%,7.0% and 0,respectively.The difference of the cancer-free survival rates between the high ESM-1 group and low ESM-1 group was significant(P0.05).Conclusion The expression of ESM-1 was not only correlated with the malignant behaviors including neovascularization and venous invasion,but also with the poor prognosis of HCC patients.
作者 黄耿文 丁翔
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第9期1035-1037,共3页 Cancer Research on Prevention and Treatment
基金 国家自然科学基金资助项目(30801386)
关键词 肝细胞癌 内皮细胞特异性分子1 预后 Hepatocellular carcinoma Endothelial cell specific molecule-1 Prognosis
  • 相关文献

参考文献10

  • 1Sherman M. Recurrence of hepatocellular carcinoma [J]. N Engl J Med, 2008, 359(19): 2045-2047.
  • 2黄耿文,杨连粤,鲁伟群,文卫.构建血管生成指数预测肝癌术后复发[J].中华实验外科杂志,2007,24(1):108-108. 被引量:3
  • 3黄耿文,杨连粤,鲁伟群,丁翔,陶一明.肝癌新生血管的形态学异常及其临床意义[J].肿瘤防治研究,2007,34(6):449-450. 被引量:5
  • 4St Croix B, Rago C, Velculescu V, et al. Genes expressed in human tumor endothelmiu [J]. Science, 2000, 289 (5482) : 1197-1202.
  • 5Yang LY, Lu WQ, Huang GW, et al. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma [J]. BMC Cancer, 2006, 6: 110.
  • 6Sarrazin S, Adam E, Lyon M, et al. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy [J]. Bioehim Biophys Acta, 2006, 1765(1) : 25-37.
  • 7Abid MR, Yi X, Yano K, et al. Vascular endocan is preferen- tially expressed in tumor endothelium[J].Microvasc Res, 2006, 72(3) 136-145.
  • 8Grigoriu BD, Depontieu F, Scherpereel A, et al. Endocan ex- pression and relationship with survival in human non-small cell lung cancer[J].Clin Cancer Res, 2006, 12(15): 4575-4582.
  • 9Borczuk AC, Shah L, Pearson GD, et al. Molecular signa- tures in biopsy specimens of lung cancer [J]. Am J Respir Crit Care Med, 2004, 170(2) : 167-174.
  • 10Amatschek S, Koenig U, Auer H, et al. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor- specific genes [J]. Cancer Res, 2004, 64(3): 844-856.

二级参考文献8

共引文献6

同被引文献17

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部